Fatal trials: clinical trials are killing people
In many quarters there is satisfaction that India is developing into the “clinical trials capital” of the globe. By all accounts the business of conducting clinical trials in India is growing at a phenomenal rate. The reasons have been discussed widely and merit only a brief mention here. Situating clinical trials in India provides the advantage of low costs (estimated as 60% lower than in developed countries), relatively high levels of technical expertise and a large population base on whom clinical trials can be conducted.
There are currently no refbacks.